Cargando…

Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2005

Detalles Bibliográficos
Autores principales:	Anan, Keisei, Fukui, Naohito, Kinoshita, Takayuki, Iwamoto, Takayuki, Niikura, Naoki, Kawai, Masaaki, Hayashi, Naoki, Tsugawa, Kouichiro, Aogi, Kenjiro, Ishida, Takanori, Masuoka, Hideji, Masuda, Sinobu, Iijima, Kotaro, Nakamura, Seigo, Tokuda, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2015
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691584/ https://www.ncbi.nlm.nih.gov/pubmed/26464008 http://dx.doi.org/10.1007/s12282-015-0645-4

Ejemplares similares

Comprehensive prognostic report of the Japanese Breast Cancer Society registry in 2006
por: Iwamoto, Takayuki, et al.
Publicado: (2015)

Comprehensive prognostic report of the Japanese Breast Cancer Society Registry in 2004
por: Kinoshita, Takayuki, et al.
Publicado: (2015)

Body mass index and survival after diagnosis of invasive breast cancer: a study based on the Japanese National Clinical Database—Breast Cancer Registry
por: Kawai, Masaaki, et al.
Publicado: (2016)

Distinct breast cancer characteristics between screen- and self-detected breast cancers recorded in the Japanese Breast Cancer Registry
por: Iwamoto, Takayuki, et al.
Publicado: (2016)

Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry
por: Kataoka, Akemi, et al.
Publicado: (2016)

A population-based recurrence risk management study of patients with pT1 node-negative HER2+ breast cancer: a National Clinical Database study
por: Kubo, Makoto, et al.
Publicado: (2019)

Efficacy and safety of pegfilgrastim biosimilar MD‐110 in patients with breast cancer receiving chemotherapy: Single‐arm phase III
por: Takano, Toshimi, et al.
Publicado: (2023)

Annual report of the Japanese Breast Cancer Society registry for 2016
por: Kubo, Makoto, et al.
Publicado: (2020)

Clinicopathological features of male patients with breast cancer based on a nationwide registry database in Japan
por: Shimomura, Akihiko, et al.
Publicado: (2022)

Challenging cases of professionalism in Japan: improvement in understanding of professional behaviors among Japanese residents between 2005 and 2013
por: Kinoshita, Kensuke, et al.
Publicado: (2015)

Bone metastasis-related signaling pathways in breast cancers stratified by estrogen receptor status
por: Hayashi, Naoki, et al.
Publicado: (2017)

Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013)
por: Watanabe, Kazuhiro, et al.
Publicado: (2015)

Immunohistochemical Ki67 after short-term hormone therapy identifies low-risk breast cancers as reliably as genomic markers
por: Iwamoto, Takayuki, et al.
Publicado: (2017)

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study
por: Kadoya, Takayuki, et al.
Publicado: (2013)

Comparison of tumor‐infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients
por: Ogiya, Rin, et al.
Publicado: (2016)

Fulvestrant with or without anti‐HER2 therapy in patients in a postmenopausal hormonal state and with ER‐positive HER2‐positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG‐C06)
por: Masuyama, Misato, et al.
Publicado: (2023)

Factors associated with prolonged overall survival in patients with postmenopausal estrogen receptor-positive advanced breast cancer using real-world data: a follow-up analysis of the JBCRG-C06 Safari study
por: Kawaguchi, Hidetoshi, et al.
Publicado: (2019)

Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
por: Aogi, Kenjiro, et al.
Publicado: (2015)

Tamoxifen plus tegafur-uracil (TUFT) versus tamoxifen plus Adriamycin (doxorubicin) and cyclophosphamide (ACT) as adjuvant therapy to treat node-positive premenopausal breast cancer (PreMBC): results of Japan Clinical Oncology Group Study 9404
por: Shien, Tadahiko, et al.
Publicado: (2014)

Inflammatory Alterations of the Extracellular Matrix in the Tumor Microenvironment
por: Iijima, Junko, et al.
Publicado: (2011)

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples
por: Iwamoto, Takayuki, et al.
Publicado: (2019)

Randomized phase II study of nab‐paclitaxel as first‐line chemotherapy in patients with HER2‐negative metastatic breast cancer
por: Tamura, Kenji, et al.
Publicado: (2017)

Characteristics of female breast cancer in japan: annual report of the National Clinical Database in 2018
por: Tada, Keiichiro, et al.
Publicado: (2022)

Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression
por: Hanamura, Toru, et al.
Publicado: (2022)

Multi-Institutional Analysis of Early Glottic Cancer from 2000 to 2005
por: Hirasawa, Naoki, et al.
Publicado: (2012)

Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
por: Hanamura, Toru, et al.
Publicado: (2023)

Correction: Expression of hormone receptors is associated with specific immunological profiles of the breast cancer microenvironment
por: Hanamura, Toru, et al.
Publicado: (2023)

Squamous Cell Carcinoma Arising From an Epidermal Cyst of the Buttock: A Case Report
por: Fukui, Michika, et al.
Publicado: (2019)

Successful bail-out of a massive air embolism during catheter ablation for atrial fibrillation
por: Shiomi, Satoko, et al.
Publicado: (2022)

A solitary giant neurofibroma of the left thigh: a case report
por: Okamoto, Maki, et al.
Publicado: (2022)

Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
por: Watanabe, Kenichi, et al.
Publicado: (2023)

Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer
por: Okamoto, Keisei, et al.
Publicado: (2020)

Changes in Recurrence Score by neoadjuvant endocrine therapy of breast cancer and their prognostic implication
por: Ueno, Takayuki, et al.
Publicado: (2019)

Conchal Cartilage Graft for Correction of Bilateral Cleft Lip Nasal Deformities during Childhood
por: Masuoka, Hiromu, et al.
Publicado: (2014)

Treatment Outcome and Prognostic Factors for Patients with Bone-Only Metastases of Breast Cancer: A Single-Institution Retrospective Analysis
por: Niikura, Naoki, et al.
Publicado: (2011)

Fosnetupitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Short Review and Clinical Perspective
por: Abe, Masakazu, et al.
Publicado: (2023)

Chemotherapy resumption in breast cancer patient after COVID-19
por: Horiguchi, Julian, et al.
Publicado: (2021)

Effectiveness, Indications, and Side Effects of Oral Propranolol Treatment for Infantile Hemangioma in Japanese Patients
por: Fukui, Michika, et al.
Publicado: (2019)

Impact of clinical response to neoadjuvant endocrine therapy on patient outcomes: a follow-up study of JFMC34-0601 multicentre prospective neoadjuvant endocrine trial
por: Ueno, Takayuki, et al.
Publicado: (2018)

Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study
por: Tanaka, Kiyo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsnrik0dklhd03esllgf2mdhpc